Ashton Thomas Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Ashton Thomas Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$321K	Buy	571 +97	+20%	+$62.2K	0.01%	861
2025 Q4	$321K	Buy	474 +82	+21%	+$55.8K	0.01%	799
2025 Q3	$250K	Buy	+392	New	+$238K	0.01%	856
2024 Q3	–	Sell	-182	Closed	-$88.7K	–	1194
2024 Q2	$88.7K	Buy	+182	New	+$91.4K	﹤0.01%	784
2024 Q1	–	Sell	-475	Closed	-$264K	–	606
2023 Q4	$264K	Sell	475 -207	-30%	-$97.2K	0.02%	514
2023 Q3	$298K	Sell	682 -56	-8%	-$27.9K	0.02%	475
2023 Q2	$371K	Sell	738 -99	-12%	-$47.4K	0.03%	449
2023 Q1	$419K	Buy	837 +134	+19%	+$64.1K	0.04%	383
2022 Q4	$287K	Buy	+703	New	+$273K	0.03%	407

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ashton Thomas Private Wealth's IDXX Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its Idexx Laboratories (IDXX) stake by 20% in Q1 2026, buying an estimated $62.2K and bringing the position to 571 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #861.

Ashton Thomas Private Wealth first reported a position in IDXX in Q4 2022 and has held it in 9 quarters since. The position peaked at $419K in Q1 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Ashton Thomas Private Wealth held 571 shares of Idexx Laboratories worth $321K as of Q1 2026.
Ashton Thomas Private Wealth bought 97 Idexx Laboratories shares in Q1 2026, an estimated $62.2K.
Idexx Laboratories made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #861 holding.
Ashton Thomas Private Wealth first reported a position in Idexx Laboratories in Q4 2022 and has held it in 9 quarters since.
Ashton Thomas Private Wealth's Idexx Laboratories position peaked at $419K in Q1 2023.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.